The Diamond McCarthy Intellectual Property team represents a client in a breach of contract lawsuit against two companies including a global Fortune 500 pharmaceutical company for improper termination of a patent license agreement, unjust enrichment and other commercial litigation claims. The technology relates to the modification of NK92 cell lines, and the legal claims represent sizable damages.
Law Firm - Houston | Dallas | Los Angeles | San Francisco | New York
Experiences